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proton stopping power ratio (SPR). In this study, we 
measured and quantified the accuracy of dual energy CT 
(DECT) SPR prediction in comparison with single energy CT 
(SECT) calibration. 
 
Material and Methods: We applied a stoichiometric 
calibration method for DECT to predict the SPR using CT 
images acquired sequentially at 80 kVp and 140 kVp. The dual 
energy index was derived based on the HUs of the paired 
spectral images and then used to calculate the effective 
atomic number, electron density, and SPR of the materials. 
The materials were irradiated with a collimated 2 mm width 
pristine pencil beam and the water equivalent thickness 
(WET) and SPRs deduced from the residual proton range 
measured using a multi-layer ion chamber (MLIC) device. 
Multiple proton energy (130 to 160 MeV) measurements were 
made on the tissues to achieve sub mm WET measurement 
accuracy. Tissue surrogates (lung, adipose, muscle and bone) 
with known chemical compositions were used for calibration 
and validated with animal tissues. The animal tissues (veal 
shanks) were kept in a frozen state during the CT scans and 
proton range measurements. The results were compared to 
traditional stoichiometric calibration with SECT at 120 kVp.  
 
Results: The percentage difference of DECT predicted SPR 
from MLIC measurements were reduced 1) from 3.9% to 0.7% 
for tissue surrogates; 2) from 1.8% to <0.1% for veal bone 
(tibia); and 3) from 1.7% to 0.9% for veal muscle compared 
with SECT calibration. The systematic uncertainties from CT 
scans were studied by varying the effective phantom size 
(<1%), surrogate locations (<1%), and repeat CT scans 
(<0.6%). The choice of the mean ionization values of the 
chemical elements resulted in a 0.2~0.9% variation in 
calculated SPRs. 
 
 
Conclusion: Our study indicated that DECT is superior to 
SECT for proton SPR prediction and has the potential to 
reduce the range uncertainty to less than 2%. DECT may 
permit the use of tighter distal and proximal range 
uncertainty margins for treatment thereby increasing the 
precision of proton therapy. 
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Purpose or Objective: To calculate the beam quality 
correction factors (kQ) in monoenergetic proton beams using 
detailed Monte Carlo simulation of ionization chambers. To 
compare the results with the kQ factors tabulated in IAEA 
TRS-398, which assume ionization chamber perturbation 
correction factors (pQ) equal to unity. 
 
Material and Methods: Two different Monte Carlo codes were 
used: (i) Gamos/Geant4 to generate a phase-space file just in 
front of the ionization chamber and (ii) PENH to simulate the 
transport of particles in the ionization chamber geometry (or 
water cavity). Seven ionization chambers (5 plane-parallel 
and 2 cylindrical) were studied, together with five proton 
beam energies (from 70 to 250 MeV). kQ calculations were 
performed using the electronic stopping powers resulting 
from the adoption of two different sets of I-values for water 
and graphite: (i) Iw = 75 eV and Ig = 78 eV, and (ii) Iw = 78 eV 
and Ig = 81 eV. 
 
Results: The kQ factors calculated using the two different 
sets of I-values were found to agree within 1.5% or better. 
The kQ factors calculated using Iw = 75 eV and Ig = 78 eV 
were found to agree within 2.3% or better with the kQ factors 
tabulated in IAEA TRS-398; and within 1% or better with 
experimental values determined with water calorimetry (see 
figure 1). The agreement with IAEA TRS-398 values was found 
to be better for plane-parallel chambers than for cylindrical. 
For cylindrical chambers, our kQ factors showed a larger 
variation with the residual range than IAEA TRS-398 values 
(see figure 1). This is, in part, due to the fact that our kQ 
factors take inherently into account the dose gradient effects 
in unmodulated proton beams. 
 
Figure 1: kQ factor of the NE 2571 cylindrical chamber, as a 
function of the residual range, (i) tabulated in IAEA TRS-398, 
(ii) calculated in this work with Monte Carlo simulation and 
(iii) determined with water calorimetry. The uncertainty bars 
correspond to one standard uncertainty in the data points. 
The dashed lines correspond to one standard uncertainty in 
the IAEA TRS-398 values. 
 
Conclusion: The results of this work seem to indicate that 
ionization chamber perturbation correction factors in 
unmodulated proton beams could be significantly different 
from unity, at least for some of the ionization chamber 
models studied here. In general, the uncertainty of Iw and Ig 
seems to have a smaller effect on kQ factors than the 
assumption of pQ equal to unity. Finally, Monte Carlo 
calculated kQ factors of plane-parallel ionization chambers 
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seem to be in better agreement with the IAEA TRS-398 values 
currently in use, than those of cylindrical chambers. 
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Purpose or Objective: Automated planning (AP) aims to 
simplify the treatment planning process by eliminating user 
variability. We performed a detailed plan comparison based 
on clinical objectives and dose-volume histogram (DVH) 
parameters in a group of stereotactic body radiation therapy 
(SBRT) lung cancer patients. 
 
Material and Methods: Between March 2012 and May 2015, 
55 lung cancer patients were treated with SBRT at our 
institution. A total dose of 60 Gy in 3 fractions was 
prescribed to the PTV (D95). For each patient, an IMRT plan 
was created using in-house developed optimization software 
by manually tweaking a set of optimization objectives during 
several iterations. Final dose calculation was performed in 
Pinnacle 9.8 (Philips Medical Systems Inc, USA). These plans 
are further referred to as the manual plans (MP). 
For each patient, an additional plan was created 
retrospectively using the Pinnacle 9.10 Auto-Planning 
software with a template representing the clinical objectives 
for the following structures: GTV, PTV, lungs minus GTV, 
spinal cord, esophagus, heart, aorta, trachea, main stem 
bronchus and chest wall. Using automatic optimization tuning 
methods, an automated plan (AP) was created for each 
patient using the same IMRT beam directions as for the MP. 
No additional manual tweaking whatsoever was performed. 
For all of the above-mentioned structures the following DVH 
parameters were included in our analysis: D99, D98, D95, 
D90, D50, D5, D2 (in which xx% of the PTV volume receives a 
dose of at least Dxx) and Dmean. For the organs at risk (OAR) 
V5, V10 and V20 were also included (in which Vxx is the 
volume receiving at least xx Gy). The acceptability of each 
plan was judged against our clinical objectives (result: pass, 
minor deviation or fail). Additionally, pairwise comparisons of 
the DVH parameters were performed using paired, two-sided 
t-tests between the MPs and APs. 
 
Results: Three APs failed in terms of our clinical objectives 
(1 plan: heart D2, 2 plans: chest wall D2), while 13 plans 
showed a minor deviation (12 plans: lungs minus GTV V20, 1 
plan: chest wall D2). None of the MPs failed our clinical 
objectives, but 9 also showed a minor deviation (8 plans: 
lungs minus GTV V20, 1 plan: PTV D99). The graph shows 
average values over all patients of the dose (in Gy) –volume 
(in %) parameters for which statistically significant (p < 0,05) 
differences were found between the MPs and APs. Top: GTV 
and PTV; bottom: clinical OAR objectives. All plans were 
normalized to PTV D95 = 60 Gy. 
 
 
Conclusion: Without user intervention, AP resulted in plans 
that comply with our clinical objectives for almost all 
patients. Some APs may require slight additional manual 
tweaking. From a statistical point of view, AP delivers 
significantly less dose to the OARs, while preserving target 
coverage. In the near future, all plans will be blindly 
evaluated by three experienced radiation oncologists to 
assess the clinical significance of the observed statistical 
differences. 
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Purpose or Objective: The ViewRay MRI-Co60 hybrid system 
(MRIdian) allows MRI based targeting, autosegmentation and 
direct planning for numerous anatomical districts. Our 
department is implementing this technology and, up to date, 
we are comparing planning procedures to our clinical 
standards in order to define which districts could take 
advantage from the use of the MRIdian technology. Aim of 
this investigation was to assess the impact of the MRIdian 
radiation therapy system through a planning analysis for 
rectal cancer treatments. 
 
Material and Methods: Ten sets of 3 plans (MRIdian, RapidArc 
and 5 beams sliding windows IMRT) were calculated for 10 
patients affected by locally advanced rectal cancer (cT3-cT4; 
cN0, cN+). ROIs were contoured on Eclipse TPS. RapidArc (6-
15 MV) and 5 beams (6-15 MV) sliding windows IMRT 
treatment plans were calculated on Eclipse according to our 
QA protocols. The PTV1 (CTV1+7 mm margin) was 
represented by tumor+1.5 cm margin craniocaudally and 
correspondent mesorectum, the PTV2 (CTV2 + 7 mm margin) 
by mesorectum in toto and pelvic nodes. The body, the bowel 
bag and the bladder were the OaR considered. The 
prescribed dose for PTV2 was 45 Gy and 55 Gy for PTV1 
through simultaneous integrated boost. The PTV V95 and 
OaRs QUANTEC dose constraints on the DVHs and Wu’s 
homogeneity indexes (HI) were considered for the QA of the 
plans. The structure sets were then uploaded on the MRIdian 
TPS and Co60 step and shoot IMRT plans (7 groups of 3 fields) 
were calculated. The DHVs and HIs were then compared to 
the RapidArc and IMRT plans in order to evaluate MRIdian’s 
performances. 
 
Results: MRIdian showed a better HI when compared to the 
other techniques for PTV1, while this advantage could not be 
appreciated for PTV2, even if a better PTV2 V100 (45 Gy) was 
observed. Comparable mean doses for the bladder were 
registered, while a higher bowel V45 was observed (even if 
still in the constraints limits). Low dose body V5 was higher 
